BFS
IDXX icon

Bradley Foster & Sargent’s Idexx Laboratories IDXX Stock Holding History

Bradley Foster & Sargent’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.8M Buy
104,140
+486
+0.5% +$273K 0.78% 37
2026
Q1 		$58.2M Sell
103,654
-1,039
-1% -$666K 0.91% 34
2025
Q4 		$70.8M Sell
104,693
-416
-0.4% -$283K 1.04% 24
2025
Q3 		$67.2M Buy
105,109
+414
+0.4% +$251K 0.99% 28
2025
Q2 		$56.2M Buy
104,695
+846
+0.8% +$405K 0.88% 32
2025
Q1 		$43.6M Buy
103,849
+15,136
+17% +$6.57M 0.75% 40
2024
Q4 		$36.7M Buy
88,713
+84,490
+2,001% +$37.1M 0.62% 46
2024
Q3 		$2.13M Buy
4,223
+3,220
+321% +$1.56M 0.04% 192
2024
Q2 		$489K Sell
1,003
-12
-1% -$6.02K 0.01% 356
2024
Q1 		$548K Sell
1,015
-125
-11% -$68.3K 0.01% 343
2023
Q4 		$633K Hold
1,140
– – 0.01% 326
2023
Q3 		$573K Hold
1,140
– – 0.01% 328
2023
Q2 		$573K Buy
1,140
+108
+10% +$51.8K 0.01% 328
2023
Q1 		$516K Buy
1,032
+59
+6% +$28.2K 0.01% 326
2022
Q4 		$397K Hold
973
– – 0.01% 349
2022
Q3 		$317K Buy
+973
New +$357K 0.01% 361
2022
Q2 		– Sell
-520
Closed -$284K – 453
2022
Q1 		$284K Buy
520
+115
+28% +$60.5K 0.01% 409
2021
Q4 		$267K Buy
+405
New +$254K 0.01% 402

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Bradley Foster & Sargent's IDXX Position: Q2 2026 in Review

Bradley Foster & Sargent increased its Idexx Laboratories (IDXX) stake by 0.47% in Q2 2026, buying an estimated $273K and bringing the position to 104,140 shares worth $54.8M. The position accounts for 0.78% of the portfolio, ranked #37.

Bradley Foster & Sargent first reported a position in IDXX in Q4 2021 and has held it in 18 quarters since. The position peaked at $70.8M in Q4 2025. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Bradley Foster & Sargent held 104,140 shares of Idexx Laboratories worth $54.8M as of Q2 2026.
  • Bradley Foster & Sargent bought 486 Idexx Laboratories shares in Q2 2026, an estimated $273K.
  • Idexx Laboratories made up 0.78% of Bradley Foster & Sargent's portfolio in Q2 2026, its #37 holding.
  • Bradley Foster & Sargent first reported a position in Idexx Laboratories in Q4 2021 and has held it in 18 quarters since.
  • Bradley Foster & Sargent's Idexx Laboratories position peaked at $70.8M in Q4 2025.
  • 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.